BMAL1 and Cerebral ischemia: Recently, Ramsey et al.'s study [45] found that the deletion of Bmal1 can reduce the activity of Nrf2 (nuclear factor E2‐related factor 2) and lead to increased production of inflammatory cytokines, which aggravates the inflammatory response in the brain of mice with cerebral ischemia–reperfusion.